Acne Vulgaris

Download PDF

Recent Publications on Acne Vulgaris:
Lack of association between the promoter polymorphisms at positions -238 and -308 of the tumour necrosis factor alpha gene and acne vulgaris in Polish patients. BACKGROUND: There are controversial reports about the role of Demodex...	16th July, 2008	Department of Dermatology, Venereology and Allergology, Medical University	J Eur Acad Dermatol Venereol. 2008 Jun 26;. DOI Direct Link
Combination of short CAG and GGN repeats in the androgen receptor gene is associated with acne risk in North East China. Background Acne vulgaris is one of the most common skin disorders, and...	16th July, 2008	Department of Dermatology, No. 1 Hospital of China Medical University; Key	J Eur Acad Dermatol Venereol. 2008 Jul 3;. DOI Direct Link
New insights into adolescent acne. PURPOSE OF REVIEW: Acne vulgaris remains one of the most common conditions...	16th July, 2008	Department of Pediatrics and Medicine (Dermatology), University of	Curr Opin Pediatr. 2008 Aug;20(4):436-40. DOI Direct Link
Lowering lesional surface pH in acne: A new treatment modality for Herpifix((R)). The acid skin surface pH has antimicrobial activities. Increased growth of...	12th July, 2008	Department of Dermatology, Environmental Medicine and Health Theory,	J Dermatolog Treat. 2008 Jul 10;:1-4. DOI Direct Link
Minocycline hepatitis. Minocycline is an effective antibiotic widely used in the treatment of...	12th July, 2008	Department of Digestive Diseases and Clinical Nutrition, Ninewells	Eur J Gastroenterol Hepatol. 2008 Aug;20(8):796-9. DOI Direct Link
→View more research publications.

BioNews Results for Acne Vulgaris:
Galderma Announces Approval for Differin Gel 0.1% in Japan	Pharma Live:  Jul 18 2008 11:51AM Matching: acne vulgaris
Galderma Announces Approval for Differin(R) Gel 0.1% in Japan	KLFY:  Jul 17 2008 12:43AM Matching: acne vulgaris
QLT to Sell Acne Vulgaris Treatment to Allergan for $150M	Genetic Engineering News:  Jun 10 2008 5:10AM Matching: acne vulgaris

Acne Vulgaris Clinical Trials:
Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne	Acne Vulgaris;   Acne;   Propionibacterium Acnes

Acne Vulgaris Patents:
US Patent No.	Title
7268148	Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
7306620	Prevention and treatment of skin and nail infections using germicidal light
7309688	Topical anti-cancer compositions and methods of use thereof
7309759	Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
7311722	Photodynamic stimulation device and methods
→View more patents.

Companies working in the area of Acne Vulgaris from Bioportfolio's Biocorporate database :
Company Name
fOCUS Pharmaceuticals, LLC fOCUS Pharmaceuticals is a privately held generic and branded pharmaceutical company specializing in the research and development of prescription dermatology products. Our primary focus are in the... www.focuspharma.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Acne Vulgaris scientists - we have details of around 778 individuals working on Acne Vulgaris .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.